Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer
5/20/2013 6:26:46 AM
More...
|
Data Presented at OARSI's 2013 World Congress on Osteoarthritis Show Flexion Therapeutics's FX006 Has Prolonged Therapeutic Concentration in Knee Joint
4/19/2013 7:34:37 AM
More...
|
Flexion Therapeutics to Present at 31st Annual J.P. Morgan Healthcare Conference
1/4/2013 7:10:10 AM
More...
|
Flexion Therapeutics's FX006 Achieves Prolonged Therapeutic Concentrations in Joints of Osteoarthritis Patients
12/17/2012 8:56:51 AM
More...
|
Flexion Therapeutics Names Arthur Fratamico Chief Business Officer
6/20/2012 10:28:58 AM
More...
|
Flexion Therapeutics Reports Positive Data for Osteoarthritis Drug
5/30/2012 8:00:33 AM
More...
|
Flexion Therapeutics Announces Agreements with Four Major Pharmaceutical Companies Such As AstraZeneca PLC (AZN) (JOBS) And Merck Serono (JOBS); Closes Series A Financing Round At $42 Million
1/29/2010 7:03:49 AM
More...
|
Flexion Therapeutics Raises $33 Million in Series A Financing
10/16/2009 1:04:11 PM
More...
|